Regulation of PARP1/2 and the tankyrases: emerging parallels
Biochemical Journal · 2024
DOI: 10.1042/bcj20230230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Journal, 2024. Verfasst von Matthew Jessop und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Structural Biology, The Institute of Cancer Research (ICR), London, U.K. Hauptthemen laut MEDLINE: Tankyrases, Poly (ADP-Ribose) Polymerase-1. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust.
Abstract (Originalsprache)
ADP-ribosylation is a prominent and versatile post-translational modification, which regulates a diverse set of cellular processes. Poly-ADP-ribose (PAR) is synthesised by the poly-ADP-ribosyltransferases PARP1, PARP2, tankyrase (TNKS), and tankyrase 2 (TNKS2), all of which are linked to human disease. PARP1/2 inhibitors have entered the clinic to target cancers with deficiencies in DNA damage repair. Conversely, tankyrase inhibitors have continued to face obstacles on their way to clinical use, largely owing to our limited knowledge of their molecular impacts on tankyrase and effector pathways, and linked concerns around their tolerability. Whilst detailed structure-function studies have revealed a comprehensive picture of PARP1/2 regulation, our mechanistic understanding of the tankyrases lags behind, and thereby our appreciation of the molecular consequences of tankyrase inhibition. Despite large differences in their architecture and cellular contexts, recent structure-function work has revealed striking parallels in the regulatory principles that govern these enzymes. This includes low basal activity, activation by intra- or inter-molecular assembly, negative feedback regulation by auto-PARylation, and allosteric communication. Here we compare these poly-ADP-ribosyltransferases and point towards emerging parallels and open questions, whose pursuit will inform future drug development efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Structural Biology, The Institute of Cancer Research (ICR), London, U.K.
- Division of Cancer Biology, The Institute of Cancer Research (ICR), London, U.K.
ORCID-Profile: Sebastian Guettler
Förderung
- Cancer Research UK
- Wellcome Trust
Zitieren
APA
Jessop, M., Broadway, B. J., Miller, K., & Guettler, S. (2024). Regulation of PARP1/2 and the tankyrases: emerging parallels. Biochemical Journal. https://doi.org/10.1042/bcj20230230
Vancouver
Jessop M, Broadway BJ, Miller K, Guettler S. Regulation of PARP1/2 and the tankyrases: emerging parallels. Biochemical Journal. 2024. doi:10.1042/bcj20230230
BibTeX
@article{Jessop2024,
author = {Jessop, Matthew and Broadway, Benjamin J and Miller, Katy and Guettler, Sebastian},
title = {Regulation of PARP1/2 and the tankyrases: emerging parallels},
journal = {Biochemical Journal},
year = {2024},
doi = {10.1042/bcj20230230}
}
EUVIMED